Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Left hippocampus sparing whole brain radiotherapy (WBRT): A planning study

T. Kazda, M. Vrzal, T. Prochazka, P. Dvoracek, P. Burkon, P. Pospisil, A. Dziacky, T. Nikl, R. Jancalek, P. Slampa, R. Lakomy

. 2017 ; 161 (4) : 397-402. [pub] 20170720

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18028563

AIMS: Unilateral sparing of the dominant (left) hippocampus during whole brain radiotherapy (WBRT) could mitigate cognitive decline, especially verbal memory, similar to the widely investigated bilateral hippocampus avoidance (HA-WBRT). The aim of this planning study is dosimetrical comparison of HA-WBRT with only left hippocampus sparing (LHA-WBRT) plans. METHODS: HA-WBRT plans for 10 patients were prepared in accordance with RTOG 0933 trial and served as baseline for comparisons with several LHA-WBRT plans prepared with an effort: 1) to maintain the same left hippocampus dosimetry ("BEST PTV") and 2) to maintain same dosimetry in planning target volume as in HA-WBRT ("BEST LH"). RESULTS: All HA-WBRT plans met RTOG 0933 protocol criteria with a mean Conformity index 1.09 and mean Homogeneity index (HI) 0.21. Mean right and left hippocampal D100% was 7.8 Gy and 8.5 Gy and mean Dmax 14.0 Gy and 13.8 Gy, respectively. "BEST PTV" plans reduced HI by 31.2% (P=0.005) which is mirrored by lower PTV_D2% (-0.8 Gy, P=0.005) and higher PTV_D98% (+1.3 Gy, P=0.005) as well as decreased optic pathway's Dmax by 1 Gy. In "BEST LH", mean D100% and Dmax for the left hippocampus were significantly reduced by 11.2% (P=0.005) and 10.9% (P=0.005) respectively. CONCLUSIONS: LHA-WBRT could improve target coverage and/or further decrease in dose to spared hippocampus. Future clinical trials must confirm whether statistically significant reduction in left hippocampal dose is also clinically significant.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18028563
003      
CZ-PrNML
005      
20180824131403.0
007      
ta
008      
180816s2017 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2017.031 $2 doi
035    __
$a (PubMed)28731074
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kazda, Tomáš $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University,Brno, Czech Republic; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0213412
245    10
$a Left hippocampus sparing whole brain radiotherapy (WBRT): A planning study / $c T. Kazda, M. Vrzal, T. Prochazka, P. Dvoracek, P. Burkon, P. Pospisil, A. Dziacky, T. Nikl, R. Jancalek, P. Slampa, R. Lakomy
520    9_
$a AIMS: Unilateral sparing of the dominant (left) hippocampus during whole brain radiotherapy (WBRT) could mitigate cognitive decline, especially verbal memory, similar to the widely investigated bilateral hippocampus avoidance (HA-WBRT). The aim of this planning study is dosimetrical comparison of HA-WBRT with only left hippocampus sparing (LHA-WBRT) plans. METHODS: HA-WBRT plans for 10 patients were prepared in accordance with RTOG 0933 trial and served as baseline for comparisons with several LHA-WBRT plans prepared with an effort: 1) to maintain the same left hippocampus dosimetry ("BEST PTV") and 2) to maintain same dosimetry in planning target volume as in HA-WBRT ("BEST LH"). RESULTS: All HA-WBRT plans met RTOG 0933 protocol criteria with a mean Conformity index 1.09 and mean Homogeneity index (HI) 0.21. Mean right and left hippocampal D100% was 7.8 Gy and 8.5 Gy and mean Dmax 14.0 Gy and 13.8 Gy, respectively. "BEST PTV" plans reduced HI by 31.2% (P=0.005) which is mirrored by lower PTV_D2% (-0.8 Gy, P=0.005) and higher PTV_D98% (+1.3 Gy, P=0.005) as well as decreased optic pathway's Dmax by 1 Gy. In "BEST LH", mean D100% and Dmax for the left hippocampus were significantly reduced by 11.2% (P=0.005) and 10.9% (P=0.005) respectively. CONCLUSIONS: LHA-WBRT could improve target coverage and/or further decrease in dose to spared hippocampus. Future clinical trials must confirm whether statistically significant reduction in left hippocampal dose is also clinically significant.
650    _2
$a nádory mozku $x radioterapie $x sekundární $7 D001932
650    _2
$a ženské pohlaví $7 D005260
650    12
$a hipokampus $7 D006624
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a léčba šetřící orgány $7 D059351
650    _2
$a kritické orgány $7 D058958
650    _2
$a dávka záření $7 D011829
650    _2
$a celková dávka radioterapie $7 D011879
650    12
$a plánování radioterapie pomocí počítače $7 D011880
650    _2
$a retrospektivní studie $7 D012189
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vrzal, Miroslav. $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0233526
700    1_
$a Procházka, Tomáš $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0135122
700    1_
$a Dvoracek, Petr $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Burkoň, Petr $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0233520
700    1_
$a Pospíšil, Petr $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0173603
700    1_
$a Dziacky, Adam $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Nikl, Tomas $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Jančálek, Radim, $u Department of Neurosurgery, St. Anne's University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Neurosurgery, St. Anne's University Hospital Brno, Brno, Czech Republic $d 1975- $7 xx0037113
700    1_
$a Šlampa, Pavel, $u Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Regional Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Brno, Czech Republic $d 1960- $7 mzk2004257405
700    1_
$a Lakomý, Radek $u Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0164218
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 161, č. 4 (2017), s. 397-402
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28731074 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20180816 $b ABA008
991    __
$a 20180823144953 $b ABA008
999    __
$a ok $b bmc $g 1328642 $s 1025518
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 161 $c 4 $d 397-402 $e 20170720 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20180816

Find record

Citation metrics

Archiving options